A Case of a Primary Small-Cell Neuroendocrine Carcinoma of the Breast

Arantxa Campos Bonel, María Teresa Murillo, Alberto Carretero-González, Luis Manuel Manso, Tomás Pascual and Javier Salamanca
Additional contact information
María Teresa Murillo: Department of Radiation oncology, Universitary 12 de Octubre Hospital, Spain
Tomás Pascual: Departmet of Medical Oncology, Universitary 12 de Octubre Hospital, Spain
Javier Salamanca: Department of Anatomical Pathology, Universitary 12 de Octubre Hospital, Spain

Cancer Therapy & Oncology International Journal, 2017, vol. 7, issue 1, 1-4

Abstract: The primary neuroendocrine tumor of the breast is a rare neoplasm, representing less than 1% of primary breast cancers. The diagnosis can only be made if non mammary sites are excluded along with the presence of characteristic immunohistochemical markers. The treatment is controversial, with no established protocol. The combination of treatments used in more common histologies, can be employed in cases of localized disease. The chemotherapy regimens most commonly used are those based on platinum (as in neuroendocrine tumors of the lung) or anthracyclines (as in breast neoplasms). The prognosis is variable, it depends on the subtype of neuroendocrine tumor and its staging; those with small-cell histology have a worse outcome. We report the case of a 55-year-old woman diagnosed with primary small-cell breast cancer and the evolution.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555701.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555701.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:7:y:2017:i:1:p:1-4

DOI: 10.19080/CTOIJ.2017.07.555701

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().